Grünenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US

AACHEN, Germany and MORRISTOWN, New Jersey, November 14, 2018 -- (Healthcare Sales & Marketing Network) - Grünenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint ... Biopharmaceuticals, Mergers & Acquisitions Grünenthal Group, Averitas Pharma, Qutenza, capsaicin
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news